Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse

International Journal of Experimental Pathology

Volumn 94, Issue 6, 2013, Pages 418-425

  Luo, Yue Bei ^a   Johnsen, Russell D ^a   Griffiths, Lisa ^b   Needham, Merrilee ^a   Fabian, Victoria A ^b   Fletcher, Sue ^a   Wilton, Steve D ^a   Mastaglia, Frank L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Amyloid ; Inclusion body myositis; MCK A PP transgenic mouse; Muscle histology; Tubular aggregates

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMYLOID PRECURSOR PROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXON; FEMALE; GENOTYPE; HISTOPATHOLOGY; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPY; MITOCHONDRIAL VOLUME; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

AMYLOID-Β; INCLUSION BODY MYOSITIS; MCK-AΒPP TRANSGENIC MOUSE; MUSCLE HISTOLOGY; TUBULAR AGGREGATES;

AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CREATINE KINASE, MM FORM; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; TRANSGENES; UP-REGULATION; VACUOLES;

EID: 84887409769     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12048     Document Type: Article

References (35)

1. Askanas V. & Engel W.K. (2003) Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-β, misfolded proteins, predisposing genes, and aging. Curr. Opin. Rheumatol. 15, 737-744.
2. Askanas V., McFerrin J., Baqué S., Alvarez R.B., Sarkozi E. & Engel W.K. (1996) Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc. Natl Acad. Sci. USA 93, 1314-1319.
3. Barnes L.M., Bentley C.M. & Dickson A.J. (2003) Stability of protein production from recombinant mammalian cells. Biotechnol. Bioeng. 81, 631-639.
4. Beckett T.L., Niedowicz D.M., Studzinski C.M. et al. (2010) Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle. Neurobiol. Dis. 39, 449-456.
5. Beyer K., Lao J.I., Carrato C. et al. (2004) Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies. Brain Res. Mol. Brain Res. 131, 131-135.
6. Boncompagni S., Moussa C.E., Levy E. et al. (2012) Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice. J. Biol. Chem. 287, 20534-20544.
7. Calderon-Garcidueñas L., Reed W., Maronpot R.R. et al. (2004) Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol. Pathol. 32, 650-658.
8. Dalakas M.C. (2005) Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 66, S33-S38.
9. Green K.N., Demuro A., Akbari Y. et al. (2008) SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production. J. Gen. Physiol. 132, 1107-1116.
10. Herring A., Lewejohann L., Panzer A.L. et al. (2011) Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol. Dis. 42, 530-538.
11. Ho L., Qin W., Pompl P.N. et al. (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB. J 18, 902-904.
12. Hooijmans C.R., Van der Zee C.E., Dederen P.J. et al. (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol. Dis. 33, 482-498.
13. Hsiao K., Chapman P., Nilsen S. et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
14. Johnston J.A., Norgren S., Ravid R. et al. (1996) Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains. Brain Res. Mol. Brain Res. 43, 85-95.
15. Kitazawa M., Vasilevko V., Cribbs D.H. & LaFerla F.M. (2009) Immunization with amyloid-β attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model. J. Neurosci. 29, 6132-6141.
16. Konig G., Salbaum J.M., Wiestler O. et al. (1991) Alternative splicing of theβA4 amyloid gene of Alzheimer's disease in cortex of control and Alzheimer's disease patients. Brain Res. Mol. Brain Res. 9, 259-262.
17. Levin-Allerhand J.A., Lominska C.E. & Smith J.D. (2002) Increased amyloid-β levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J. Nutr. Health Aging 6, 315-319.
18. 2+ dysregulation in skeletal muscle. Muscle Nerve 42, 731-738.
19. Menéndez-González M., Pérez-Pinera P., Martínez-Rivera M., Calatayud M.T. & Blázquez Menes B. (2005) APP processing and the APP-KPI domain involvement in the amyloid cascade. Neurodegener. Dis. 2, 277-283.
20. Migliaccio A.R., Bengra C., Ling J. et al. (2000) Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells. Gene 256, 197-214.
21. Moir R.D. & Tanzi R.E. (2005) LRP-mediated clearance of Aβ is inhibited by KPI-containing isoforms of APP. Curr. Alzheimer Res. 2, 269-273.
22. Moussa C.E., Fu Q., Kumar P. et al. (2006) Transgenic expression of β-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. FASEB J 20, 2165-2167.
23. Needham M. & Mastaglia F. (2008) Sporadic inclusion body myositis: a continuing puzzle. Neuromuscul. Disord. 18, 6-16.
24. -/- mice. Eur. J. Cell Biol. 81, 101-106.
25. Oyama F., Shimada H., Oyama R., Titani K. & Ihara Y. (1991) Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau. J. Neuropathol. Exp. Neurol. 50, 560-578.
26. Roy B., Shukla S., Stoermann B., Kremmer E., Duber S. & Weiss S. (2009) Loss of lambda2(315) transgene copy numbers influences the development of B1 cells. Mol. Immunol. 46, 1542-1550.
27. Salviati G., Pierobon-Bormioli S., Betto R. et al. (1985) Tubular aggregates: sarcoplasmic reticulum origin, calcium storage ability, and functional implications. Muscle Nerve 8, 299-306.
28. (-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. Am. J. Pathol. 170, 316-333.
29. 2+ release and contractility in skeletal muscle. Neurobiol. Aging 31, 2080-2090.
30. Sugarman M.C., Yamasaki T.R., Oddo S. et al. (2002) Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle. Proc. Natl Acad. Sci. USA 99, 6334-6339.
31. Sugarman M.C., Kitazawa M., Baker M., Caiozzo V.J., Querfurth H.W. & LaFerla F.M. (2006) Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. Neurobiol. Aging 27, 423-432.
32. Vattemi G., Nogalska A., Engel W.K., D'Agostino C., Checler F. & Askanas V. (2009) Amyloid-β42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol. 117, 569-574.
33. Wang J., Ho L., Qin W. et al. (2005) Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19, 659-661.
34. Zhan S.S., Sandbrink R., Beyreuther K. & Schmitt H.P. (1995) APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis. Clin. Neuropathol. 14, 142-149.
35. Zhao J., Sun X., Yu Z. et al. (2011) Exposure to pyrithiamine increases Neuropathol Appl Neurobiol-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain. Neurotox. Res. 19, 575-583.